Metformin
KY20212212-C-1
Approved small_molecule completed
Quick answer
Metformin for Gastric Intestinal Metaplasia is a Approved program (small_molecule) at Xijing Hospital of Digestive Diseases with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xijing Hospital of Digestive Diseases
- Indication
- Gastric Intestinal Metaplasia
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed